1. Home
  2. STRA vs GENB Comparison

STRA vs GENB Comparison

Compare STRA & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strategic Education Inc.

STRA

Strategic Education Inc.

HOLD

Current Price

$81.05

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.20

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STRA
GENB
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
STRA
GENB
Price
$81.05
$15.20
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$87.00
$23.20
AVG Volume (30 Days)
316.0K
484.7K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.04%
N/A
EPS Growth
15.85
N/A
EPS
3.19
N/A
Revenue
$997,137,000.00
N/A
Revenue This Year
$4.71
N/A
Revenue Next Year
$4.67
$16.58
P/E Ratio
$25.08
N/A
Revenue Growth
57.23
N/A
52 Week Low
$69.70
$11.00
52 Week High
$89.73
$18.18

Technical Indicators

Market Signals
Indicator
STRA
GENB
Relative Strength Index (RSI) 49.94 56.24
Support Level $74.47 $11.82
Resistance Level $84.77 $15.05
Average True Range (ATR) 3.58 0.80
MACD -0.24 0.15
Stochastic Oscillator 34.90 88.46

Price Performance

Historical Comparison
STRA
GENB

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: